• Phone: +1-631-791-1145
  • Email: sales@imarcgroup.com

Depression Drugs Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024

The global depression drugs market is expected to grow at a CAGR of 2.5% during 2019-2024. Depression drugs, or antidepressants, are a range of medications that are consumed for the treatment of mental disorders such as social anxiety and depression. They are intended to balance the functioning of neurotransmitters such as serotonin in the brain, thus controlling the mood and emotions of the patient. Depression and related mental disorders are characterized by the absence of positive emotions, constant low mood and numerous cognitive, physical, behavioral and emotional symptoms. These drugs can assist in relieving the symptoms of anxiety, seasonal affective disorder and dysthymia. Antidepressant medications include the use of Selective Serotonin Reuptake Inhibitors (SSRIs), atypical antidepressants and Monoamine Oxidase Inhibitors (MAOIs) that are most effective when consumed along with regular therapeutic sessions.

Depression Drugs Market

The growing prevalence of major depressive disorders across the globe is the key factor driving the growth of the market. Depression in adolescents and adults is increasing due to several factors including social isolation, improper dietary habits and work-life imbalance. Furthermore, the increasing geriatric population across the globe that suffers from isolation from family and friends, along with other health-related issues, are also augmenting the growth of the market. However, there is rising awareness about depression as a psychological issue and methodologies to cure it, which has enhanced the adoption of these drugs among patients of all age groups. Additionally, the emergence of novel techniques for the development of antidepressants with minimal side-effects and prolonged results, along with the acceptance of new medications, is also favoring the market growth. For instance, psychedelics such as ketamine are widely considered to ease the symptoms of depression and provide relief.

IMARC Group’s latest report provides a deep insight into the global depression drugs market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. This report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the depression drugs market in any manner.

Report Coverage:

  • Historical, Current and Future Market Trends
     
  • Market Breakup by Drug Class:
    • Atypical Antipsychotics
    • Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
    • Selective Serotonin Reuptake Inhibitors (SSRIs)
    • Central Nervous System (CNS) Stimulants
    • Tricyclic Antidepressants
    • Monoamine Oxidase Inhibitors
    • Others
       
  • Market Breakup by Disorder Type:
    • Major Depressive Disorder
    • Obsessive-Compulsive Disorder
    • Generalized Anxiety Disorder
    • Panic Disorder
    • Others
       
  • Market Breakup by Drug Type:
    • Generic Drugs
    • Branded Drugs
       
  • Market Breakup by Distribution Channel:
    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    • Others
       
  • Market Breakup by Region:
    • North America
    • Europe
    • Asia Pacific
    • Middle East and Africa
    • Latin America
       

Competitive Landscape:
The report has also analyzed the competitive landscape of the market with some of the key players being Otsuka Pharmaceutical, Pfizer, Eli Lilly and Company, AstraZeneca, Novartis, Bristol-Myers Squibb, GlaxoSmithKline, Takeda Pharmaceutical Company, Allergan, Johnson & Johnson, Zhejiang NHU Company Ltd, Sebela Pharmaceuticals, etc.

Key Questions Answered in This Report:

  • How has the global depression drugs market performed so far and how will it perform in the coming years?
  • What are the key regional markets in the global depression drugs industry?
  • What is the breakup of the market based on the drug class?
  • What is the breakup of the market based on the disorder type?
  • What is the breakup of the market based on the drug type?
  • What is the breakup of the market based on the distribution channel?
  • What are the various stages in the value chain of the global depression drugs industry?
  • What are the key driving factors and challenges in the global depression drugs industry?
  • What is the structure of the global depression drugs industry and who are the key players?
  • What is the degree of competition in the global depression drugs industry?

1    Preface
2    Scope and Methodology

    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3    Executive Summary
4    Introduction

    4.1    Overview
    4.2    Key Industry Trends
5    Global Depression Drugs Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Market Breakup by Drug Class
    5.4    Market Breakup by Disorder Type
    5.5    Market Breakup by Drug Type
    5.6    Market Breakup by Distribution Channel
    5.7    Market Breakup by Region
    5.8    Market Forecast
6    Market Breakup by Drug Class
    6.1    Atypical Antipsychotics 
        6.1.1    Market Trends
        6.1.2    Market Forecast
    6.2    Serotonin-Norepinephrine Reuptake Inhibitors (SNRIs)
        6.2.1    Market Trends
        6.2.2    Market Forecast
    6.3    Selective Serotonin Reuptake Inhibitors (SSRIs)
        6.3.1    Market Trends
        6.3.2    Market Forecast
    6.4    Central Nervous System (CNS) Stimulants
        6.4.1    Market Trends
        6.4.2    Market Forecast
    6.5    Tricyclic Antidepressants
        6.5.1    Market Trends
        6.5.2    Market Forecast
    6.6    Monoamine Oxidase Inhibitors
        6.6.1    Market Trends
        6.6.2    Market Forecast
    6.7    Others
        6.7.1    Market Trends
        6.7.2    Market Forecast
7    Market Breakup by Disorder Type
    7.1    Major Depressive Disorder
        7.1.1    Market Trends
        7.1.2    Market Forecast
    7.2    Obsessive-Compulsive Disorder
        7.2.1    Market Trends
        7.2.2    Market Forecast
    7.3    Generalized Anxiety Disorder
        7.3.1    Market Trends
        7.3.2    Market Forecast
    7.4    Panic Disorder 
        7.4.1    Market Trends
        7.4.2    Market Forecast
    7.5    Others 
        7.5.1    Market Trends
        7.5.2    Market Forecast
8    Market Breakup by Drug Type
    8.1    Generic Drugs
        8.1.1    Market Trends
        8.1.2    Market Forecast
    8.2    Branded Drugs
        8.2.1    Market Trends
        8.2.2    Market Forecast
9    Market Breakup by Distribution Channel
    9.1    Hospital Pharmacies
        9.1.1    Market Trends
        9.1.2    Market Forecast
    9.2    Retail Pharmacies
        9.2.1    Market Trends
        9.2.2    Market Forecast
    9.3    Online Pharmacies
        9.3.1    Market Trends
        9.3.2    Market Forecast
    9.4    Others
        9.4.1    Market Trends
        9.4.2    Market Forecast
10    Market Breakup by Region
    10.1    North America
        10.1.1    Market Trends
        10.1.2    Market Forecast
    10.2    Europe
        10.2.1    Market Trends
        10.2.2    Market Forecast
    10.3    Asia Pacific
        10.3.1    Market Trends
        10.3.2    Market Forecast
    10.4    Middle East and Africa
        10.4.1    Market Trends
        10.4.2    Market Forecast
    10.5    Latin America
        10.5.1    Market Trends
        10.5.2    Market Forecast
11    SWOT Analysis
    11.1    Overview
    11.2    Strengths
    11.3    Weaknesses
    11.4    Opportunities
    11.5    Threats
12    Value Chain Analysis
13    Porter’s Five Forces Analysis

    13.1    Overview
    13.2    Bargaining Power of Buyers
    13.3    Bargaining Power of Suppliers
    13.4    Degree of Competition
    13.5    Threat of New Entrants
    13.6    Threat of Substitutes
14    Price Analysis
15    Competitive Landscape

    15.1    Market Structure
    15.2    Key Players
    15.3    Profiles of Key Players
        15.3.1    Otsuka Pharmaceutical
        15.3.2    Pfizer
        15.3.3    Eli Lilly and Company
        15.3.4    AstraZeneca
        15.3.5    Novartis
        15.3.6    Bristol-Myers Squibb
        15.3.7    GlaxoSmithKline
        15.3.8    Takeda Pharmaceutical Company
        15.3.9    Allergan
        15.3.10   Johnson & Johnson
        15.3.11   Zhejiang NHU Company Ltd
        15.3.12   Sebela Pharmaceuticals


List of Figures

Figure 1: Global: Depression Drugs Market: Major Drivers and Challenges
Figure 2: Global: Depression Drugs Market: Sales Value (in Billion US$), 2013-2018
Figure 3: Global: Depression Drugs Market: Breakup by Drug Class (in %), 2018
Figure 4: Global: Depression Drugs Market: Breakup by Disorder Type (in %), 2018
Figure 5: Global: Depression Drugs Market: Breakup by Drug Type (in %), 2018
Figure 6: Global: Depression Drugs Market: Breakup by Distribution Channel (in %), 2018
Figure 7: Global: Depression Drugs Market: Breakup by Region (in %), 2018
Figure 8: Global: Depression Drugs Market Forecast: Sales Value (in Billion US$), 2019-2024
Figure 9: Global: Depression Drugs Industry: SWOT Analysis
Figure 10: Global: Depression Drugs Industry: Value Chain Analysis
Figure 11: Global: Depression Drugs Industry: Porter’s Five Forces Analysis
Figure 12: Global: Depression Drugs (Atypical Antipsychotics) Market: Sales Value (in Million US$), 2013 & 2018
Figure 13: Global: Depression Drugs (Atypical Antipsychotics) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 14: Global: Depression Drugs (Serotonin-Norepinephrine Reuptake Inhibitors) Market: Sales Value (in Million US$), 2013 & 2018
Figure 15: Global: Depression Drugs (Serotonin-Norepinephrine Reuptake Inhibitors) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 16: Global: Depression Drugs (Selective Serotonin Reuptake Inhibitors) Market: Sales Value (in Million US$), 2013 & 2018
Figure 17: Global: Depression Drugs (Selective Serotonin Reuptake Inhibitors) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 18: Global: Depression Drugs (Central Nervous System (CNS) Stimulant) Market: Sales Value (in Million US$), 2013 & 2018
Figure 19: Global: Depression Drugs (Central Nervous System (CNS) Stimulant) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 20: Global: Depression Drugs (Tricyclic Antidepressants) Market: Sales Value (in Million US$), 2013 & 2018
Figure 21: Global: Depression Drugs (Tricyclic Antidepressants) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 22: Global: Depression Drugs (Monoamine oxidase inhibitors) Market: Sales Value (in Million US$), 2013 & 2018
Figure 23: Global: Depression Drugs (Monoamine oxidase inhibitors) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 24: Global: Depression Drugs (Other Drug Classes) Market: Sales Value (in Million US$), 2013 & 2018
Figure 25: Global: Depression Drugs (Other Drug Classes) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 26: Global: Depression Drugs (Major Depressive Disorder) Market: Sales Value (in Million US$), 2013 & 2018
Figure 27: Global: Depression Drugs (Major Depressive Disorder) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 28: Global: Depression Drugs (Obsessive-Compulsive Disorder) Market: Sales Value (in Million US$), 2013 & 2018
Figure 29: Global: Depression Drugs (Obsessive-Compulsive Disorder) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 30: Global: Depression Drugs (Generalized Anxiety Disorder) Market: Sales Value (in Million US$), 2013 & 2018
Figure 31: Global: Depression Drugs (Generalized Anxiety Disorder) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 32: Global: Depression Drugs (Panic Disorder) Market: Sales Value (in Million US$), 2013 & 2018
Figure 33: Global: Depression Drugs (Panic Disorder) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 34: Global: Depression Drugs (Other Disorder Types) Market: Sales Value (in Million US$), 2013 & 2018
Figure 35: Global: Depression Drugs (Other Disorder Types) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 36: Global: Depression Drugs (Generic Drugs) Market: Sales Value (in Million US$), 2013 & 2018
Figure 37: Global: Depression Drugs (Generic Drugs) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 38: Global: Depression Drugs (Branded Drugs) Market: Sales Value (in Million US$), 2013 & 2018
Figure 39: Global: Depression Drugs (Branded Drugs) Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 40: Global: Depression Drugs Market: Sales through Hospital Pharmacies (in Million US$), 2013 & 2018
Figure 41: Global: Depression Drugs Market Forecast: Sales through Hospital Pharmacies (in Million US$), 2019-2024
Figure 42: Global: Depression Drugs Market: Sales through Retail Pharmacies (in Million US$), 2013 & 2018
Figure 43: Global: Depression Drugs Market Forecast: Sales through Retail Pharmacies (in Million US$), 2019-2024
Figure 44: Global: Depression Drugs Market: Sales through Online Pharmacies (in Million US$), 2013 & 2018
Figure 45: Global: Depression Drugs Market Forecast: Sales through Online Pharmacies (in Million US$), 2019-2024
Figure 46: Global: Depression Drugs Market: Sales through Other Distribution Channels (in Million US$), 2013 & 2018
Figure 47: Global: Depression Drugs Market Forecast: Sales through Other Distribution Channels (in Million US$), 2019-2024
Figure 48: North America: Depression Drugs Market: Sales Value (in Million US$), 2013 & 2018
Figure 49: North America: Depression Drugs Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 50: Europe: Depression Drugs Market: Sales Value (in Million US$), 2013 & 2018
Figure 51: Europe: Depression Drugs Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 52: Asia Pacific: Depression Drugs Market: Sales Value (in Million US$), 2013 & 2018
Figure 53: Asia Pacific: Depression Drugs Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 54: Middle East and Africa: Depression Drugs Market: Sales Value (in Million US$), 2013 & 2018
Figure 55: Middle East and Africa: Depression Drugs Market Forecast: Sales Value (in Million US$), 2019-2024
Figure 56: Latin America: Depression Drugs Market: Sales Value (in Million US$), 2013 & 2018
Figure 57: Latin America: Depression Drugs Market Forecast: Sales Value (in Million US$), 2019-2024


List of Tables

Table 1: Global: Depression Drugs Market: Key Industry Highlights, 2018 and 2024
Table 2: Global: Depression Drugs Market Forecast: Breakup by Drug Class (in Million US$), 2019-2024
Table 3: Global: Depression Drugs Market Forecast: Breakup by Disorder Type (in Million US$), 2019-2024
Table 4: Global: Depression Drugs Market Forecast: Breakup by Drug Type (in Million US$), 2019-2024
Table 5: Global: Depression Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2019-2024
Table 6: Global: Depression Drugs Market Forecast: Breakup by Region (in Million US$), 2019-2024
Table 7: Global: Depression Drugs Market Structure
Table 8: Global: Depression Drugs Market: Key Players

Note: We value your privacy and will never rent or sell your email address. Privacy policy

Purchase Options




$ 1999

REACH OUT TO US

Call us on

( US: +1-631-791-1145 )
( UK: +44-702-409-7331 )
( India: +91-120-433-0800 )


Drop us an email at

sales@imarcgroup.com

Social Links